- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- March 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- February 2024
- 135 Pages
Global
From €4317EUR$4,750USD£3,666GBP
- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,045GBP
Eletriptan is a medication used to treat migraine headaches. It is a member of the triptan class of drugs, which are serotonin receptor agonists. Eletriptan works by narrowing the blood vessels around the brain, reducing inflammation and relieving pain. It is available in tablet form and is taken orally. It is usually taken at the onset of a migraine attack and can provide relief within two hours. It is not recommended for use in pregnant or breastfeeding women.
Eletriptan is one of several medications used to treat migraine headaches. Other medications in this class include sumatriptan, naratriptan, and rizatriptan. These medications are used to treat moderate to severe migraine headaches and can provide relief within two hours. They are generally well tolerated and have few side effects.
The eletriptan market is a subset of the larger Central Nervous System Drugs market. This market includes medications used to treat a variety of neurological conditions, including migraine headaches, epilepsy, and Parkinson's disease.
Companies in the eletriptan market include GlaxoSmithKline, Merck, and Pfizer. These companies manufacture and distribute eletriptan tablets for the treatment of migraine headaches. Show Less Read more